Retrophin Inc.

(RTRX) Trade

By |

Profile

Retrophin Inc is a pharmaceutical company based in the United States. Its drug candidates are targeted at serious rare diseases such as gallstones and bile acid synthesis disorders.

Contact Information

Website: www.retrophin.com
Main Phone: +1 760 260-8600
Address: 3721 Valley Centre Drive
Address 2: Suite 200
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92130

Issuer Information

Exchange: NSD
CEO: Stephen Aselage
Employees: 173
NAICS: Medicinal and Botanical Manufacturing (325411)
$ 30.35 $ -0.59 (-1.91%)
Last Price 30.35 Change $ -0.59 Change % -1.91 Tick N/A
Bid 0. Bid Size 0.00 Ask 0. Ask Size 0.00
Open 30.94 High 31.08 Low 30.08 Prev Close 30.94
Last Trade Volume 148,720 52 Wk Hi 31.87 52 Wk Low 19.57
Market Cap 1.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 39,943,960.00 EPS (TTM) -1.70 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 12 24
Number of Buys 12 18
Number of Sells 0 6
Net Activity 76000 56528
Last 10 Buys Shares
Stephen Aselage 1,000
Jeffrey A. Meckler 1,000
Jeffrey A. Meckler 1,000
Jeffrey A. Meckler 1,000
Stephen Aselage 1,000
Steve Richardson 1,000
Stephen Aselage 1,000
Cornelius E. Golding 1,000
Martin Shkreli 1,000
Martin Shkreli 1,000
Last 10 Sell Shares
William E. Rote 1,000
Elizabeth E. Reed 1,000
Neil McFarlane 1,000
Stephen Aselage 1,000
Stephen Aselage 1,000
Alvin Shih 1,000
Alvin Shih 1,000
Alvin Shih 1,000
Alvin Shih 1,000
Stephen Aselage 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 43 43 43 43
Low Target Price Estimate 38 38 38 38
Mean Target Price Estimate 40.5 40.5 40.5 40.5
Standard Deviation 3.54 3.54 3.54 3.54
Date of Most Recent Estimate 04/04/18 04/04/18 04/04/18 04/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1